Rheumatoid Arthritis Clinical Trials in Chicago

Showing 2501-2520 of 3,348 trials

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

NCT01907802

This phase I trial studies the side effects and best dose of dabrafenib in treating patients with solid tumors and kidney or liver dysfunction. Dabrafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

BRAF Gene MutationHepatic ComplicationRenal Failure+1 more

National Cancer Institute (NCI)8 participantsStarted Aug 2013

Duarte, California, United States • Los Angeles, California, United States • Sacramento, California, United States +15 more locations

COMPLETEDPhase 22.2 miles

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract

NCT02254408

The primary objective of this study is to evaluate the effect of presatovir on respiratory syncytial virus (RSV) viral load in autologous or allogeneic hematopoietic cell transplant (HCT) recipients with an acute RSV upper respiratory tract infection (URTI), the effect of presatovir on development of lower respiratory tract complication, being free of any supplemental oxygen progression to respiratory failure, and pharmacokinetics (PK), safety, and tolerability of presatovir.

Respiratory Syncytial Virus

Gilead Sciences189 participantsStarted Jan 2015

Phoenix, Arizona, United States • Duarte, California, United States • Los Angeles, California, United States +65 more locations

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract

Rheumatoid Arthritis Trials in Other Cities

Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors

Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma

Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis

Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate

Intraoperative Liposomal Bupivacaine vs. Bupivacaine for Total Hip Replacement Pain Management

TARGET Intracranial Aneurysm Coiling Registry

Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines

A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects

Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs)

A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma

Transfusion Requirements in Cardiac Surgery III

Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women

A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines

Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas

Pilot Study of X-82 in Patients With Wet AMD

Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH

Other Conditions in Chicago